ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/15/2021
Closing price: 275.84
Support price level: $274.84
Resistance price level: N/A
Relative strength index (14-day RSI) 75.8
Beta 0.61
  • Up 9.2 percent, BIIB is one of this week's biggest gainers.

  • Volatility is forecast to fall over the next month.

  • With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$236.26 $355.63 37.9%
200 day 50 day 20 day 10 day
$278.37 $253.44 $253.50 $259.78
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
44.2% 35.3% 40.8% 44.7%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 11.1% in the next week.

  • 25.3% in the next month.

  • 107.7% in the next year.